Rapid Dose Provides Update on Common Share Private Placement
Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that...
Pharmaceutical
Gareth Williams appointed CEO of Bionical Health
WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to...
Tang Prize in Biopharmaceutical Science Honoring Three Scientists
TAIPEI, June 19, 2024 /PRNewswire/ -- In a continuing series of laureate announcements, the Tang Prize Foundation today (June 19th) announced...
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host...
IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution
Combined entity delivers the ICyte® revenue optimization platform powered by first-party data, AI-enabled data exploration, and field intelligence and alerting...
Cosmo’s Oral Diagnostic Drug Lumeblue(R) Receives Approval of New Drug Application in China
Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) reported that its partner...
Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo: Pioneering Point-of-Care Medical Imaging and Interventions with Next Generation MRI Systems
PENNINGTON, N.J., June 18, 2024 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the Venture Capital (VC) arm of Zydus...
Healthcare BPO Market Anticipates USD 626.6 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™
CHICAGO, June 18, 2024 /PRNewswire/ -- The Healthcare BPO market is projected to grow from USD 395.3 billion in 2024 to USD...
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally
COLOGNE, Germany, June 18, 2024 /PRNewswire/ -- Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate...
CO2Meter Launches GasLab® Industrial Fixed Gas Detector Series
CO2Meter launches new Industrial Gas Detector Series featuring up to 128 sensor capabilities ORMOND BEACH, Fla., June 18, 2024 /PRNewswire/...
Axtria Announces its First Ignite Leadership Award Honorees
Award Honors Top Executives Fueling Innovation and Impact in the Life Sciences Industry BERKELEY HEIGHTS, N.J., June 18, 2024 /PRNewswire/ --...
Petauri Adds Mtech Access and Delta Hat in Global Expansion
Rapidly growing pharmaceutical services platform announces transformational expansion, acquiring two leading businesses focused on evidence-based value demonstration and global market...
Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent
CHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be...
Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debtInterest...
Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
TORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in...
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
NOTE CHANGE IN DATE OF UPDATE CALL TO THURSDAY JUNE 20thCANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences,...
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
- First Patient Dosed in Expanded Access Program and Enrollment Ongoing -IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CG...